MedPath

Fidia Pharma USA Inc.

Fidia Pharma USA Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Osteoarthritis, Knee
Patellofemoral Osteoarthritis
Interventions
Device: HYMOVIS plus Physical Exercise Program (PEP)
Other: Physical Exercise Program (PEP) alone
First Posted Date
2017-09-13
Last Posted Date
2020-07-21
Lead Sponsor
Fidia Pharma USA Inc.
Target Recruit Count
148
Registration Number
NCT03281837
Locations
🇺🇸

Tucson Orthopaedic Institute Research Center, Tucson, Arizona, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

IntegraTrials LLC / OrthoVirginia, Arlington, Virginia, United States

and more 7 locations
© Copyright 2025. All Rights Reserved by MedPath